Hello Angelica Loskog!

Life Science Sweden would like to know more about Angelica Loskog and interviews her about her life as a researcher.

Uppsala-based company wins important patent dispute – but the decision is subject to appeal

A US district court has ruled in favour of Orexo in a dispute over the patent protecting the Swedish company’s drug Zubsolv, developed for treating patients wit...

Column: "Are we already living in the new normal?"

2020 felt like the year that we were building the house around us whilst moving into it at the same time.

The MathWorks

Fast Optical Sectioning of Developing Organisms and Tissue Microstructures

ZEISS Lattice SIM 3 exploits the full potential of the SIM Apotome technology.

The new ZEISS Celldiscoverer 7 has been launched

Adaptable automation for advanced workflows.

Bolag tiodubblade läkemedelpris – döms till miljardböter

En brittisk appellationsdomstol har fastställt en bötessumma på 99 miljoner pund, motsvarande nästan 1,3 miljarder kronor, för ägarna av läkemedelsbolaget Advan...

Promising Alzheimer’s study data sends Bioarctic stock soaring

The drug candidate lecanemab from Swedish company Bioarctic significantly slowed down the deterioration in patients with early on-set Alzheimer’s, according to ...

Ny upptäckt kring telomerernas DNA – kan koda för proteiner

Telomererna, som sitter i ändarna av DNA-molekylen, har fler funktioner än vi tidigare trott, menar forskare från University of North Carolina, UNC, school of medicine.

Novavax is developing a vaccine candidate against Covid-19 and seasonal flu

A combined vaccine against both Covid-19 and seasonal flu is showing promising results in studies, according to the American drug developer Novavax. The adjuvan...

CAR-T-terapin Carvykti rekommenderas i Sverige – behandling förbereds

Karolinska universitetssjukhuset har för första gången i Sverige inlett förberedelser för att behandla en patient med blodcancerformen multipelt myelom med CAR-...

NorthX Biologics Matfors AB

Double up for Korbinian Löbmann

This year, Korbinian Löbmann will moderate the New Updates in Drug Formulation & Bioavailability meeting in Copenhagen for the fifth time. Furthermore, he will ...

Anders Blanck about his 17 years at Lif: “The industry is enjoying greater public trust now"

The announcement came as a surprise to those around him, but according to the protagonist himself, the timing was excellent. Anders Blanck is now leaving Lif – ...

Claims of life science companies fleeing abroad is a myth according to survey

The claim that life science companies are moving abroad is exaggerated. In fact, only a tiny percentage is leaving the country, according to a survey.

A billion-dollar acquisition makes Novo Nordisk even bigger in obesity

Danish pharmaceutical giant Novo Nordisk acquires Montreal-based Inversago Pharma, which develops treatments for obesity and diabetes.

Delivering drugs with small devices

There are many challenges to overcome when delivering a drug orally. Getting the drug to survive the low pH of the ventricle and being released at the correct s...

Jazz anklagas för falskspel – går med på förlikning

Irländska Jazz Pharmaceuticals har gått med på att betala 145 miljoner dollar i förlikning efter anklagelser om brott mot amerikanska konkurrenslagar.

Collaboration for a simpler production of gene therapies launched

A collaboration between universities and companies aims at providing better production methods for the development of gene therapies. The initiative is led by J...

Trump i nytt försök att pressa läkemedelspriser

USA:s president Donald Trump meddelade på söndagen att han tänker underteckna en presidentorder för att sänka priserna på receptbelagda läkemedel till samma niv...

Cytel Inc acquires the SDS Group

The multinational statistical software developer and contract research organization Cytel Inc, headquartered in Massachusetts, USA, acquires the Swedish consult...

Introducing ZEISS arivis Pro 4.2

Your solution for advanced image analysis and visualization.

Novo Nordisk sues compounding pharmacies in the US

Novo Nordisk is suing compounding pharmacies in Florida, USA, because the company claims to have found impurities in the active ingredient in the obesity drug Wegovy.

Konsultbolag slås ihop – Scandinavian CRO och Qadvis blir Aurevia

Scandinavian CRO och Qadvis har nu bägge officiellt blivit en del av Aurevia, och tar därmed det nya bolagets namn.